Research and Markets: Examine the M&A Activity of the Generics Company - Apotex Inc.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31925) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Apotex Generics Company Intelligence Report to their offering Our generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the companys active product lines and ANDA ANDA abbr. abbreviated new drug application approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . Topics Covered Executive Summary Introduction Products Apotex ANDA Approvals, 2002-06 Novex Pharma ANDA Approvals, 2002-05 TorPharm ANDA Approvals, 2002-05 Plavix (clopidogrel) Bristol-Myers Squibb and sanofi-aventis respond. Court orders Apotex to halt sales of clopidogrel Recent product approvals Diltiazem hydrochloride Clopidogrel Zonisamide Ofloxacin otic Leflunomide tablets Fosinopril Haloperidol Desmopressin acetate nasal spray Financial results Cangene Cangene Financial Results, 2000-05 (C$000s) Major developments Apotex opens new R&D facility, expands other plants Mergers, acquisitions and agreements Akorn and Apotex sign ophthalmics agreement. Orchid Chemicals & Pharmaceuticals BioGeneriX Litigation Unigene/Upsher-Smith file patent infringement lawsuit against Apotex. Allergan wins Acular patent infringement lawsuit Amlodipine Court favours Alpharmas gabapentin exclusivity Contact Details Summary Apotex Inc. is the largest Canadian-owned pharmaceutical company. Founded with two employees in 1974, it now employs over 6,000 people; 5,300 of them are based in Canada, and the company has over 1,800 scientific staff. With a number of subsidiaries in Canada, Apotex is also active in around 115 countries, including subsidiaries, joint ventures or licensing agreements in Asia, Europe and Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. . Products are sold under the Apotex brand, and under customer brand names. API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol. manufacturing is largely done at Apotex Pharmachem, formerly known as Brantford Chemicals. In 2006, Apotex received eleven ANDA approvals, including one for clopidogrel clopidogrel /clo·pid·o·grel/ (klo-pid´o-grel) a platelet inhibitor used as an antithrombotic for the prevention of myocardial infarction, stroke, and vascular death in patients with atherosclerosis; used as the bisulfate salt. bisulphate Bi`sul´phate n. 1. (Chem.) A sulphate in which but half the hydrogen of the acid is replaced by a positive element or radical, thus making the proportion of the acid to the positive or basic portion twice what it is in the normal , the generic form of sanofi-aventis' Plavix. In a lucrative but controversial and potentially very risky move, Apotex launched its version in August 2006 without waiting for the attendant ATTENDANT. One who owes a duty or service to another, or in some sort depends upon him. Termes de la Ley, h.t. As to attendant terms, see Powell on Morts. Index, tit. Attendant term; Park on Dower, c. 1 7. legal issues to be resolved. Through Cangene, Apotex is active in the biosimilar area. One product, Leucotropin, is under review in Canada, while the company has plans to submit a human growth hormone human growth hormone (HGH): see growth hormone. product in the USA soon. Cangene signed an agreement with BioGeneriX, a subsidiary of ratiopharm, in 2003. Companies Mentioned * Akorn * Orchid Chemicals & Pharmaceuticals * BioGeneriX For more information visit http://www.researchandmarkets.com/reports/c31925 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion